Asia Medical Tourism Market Summary
As per Market Research Future Analysis, the Asia Medical Tourism Market was valued at 58.83 USD Billion in 2024 and is projected to grow to 135.50 USD Billion by 2034, with a CAGR of approximately 8.70% from 2025 to 2034. The market is driven by high-quality healthcare services, advanced medical technologies, and internationally accredited facilities. Countries like South Korea, Thailand, and India are particularly noted for their cosmetic treatments, attracting a significant number of medical tourists. The private healthcare sector dominates the market, providing personalized care and shorter waiting times, which enhances the appeal of Asian medical services to international patients.
Key Market Trends & Highlights
The Asia Medical Tourism Market is characterized by several key trends.
- Market Size in 2024: 58.83 USD Billion; Expected to reach 135.50 USD Billion by 2034.
- CAGR from 2025 to 2034: Approximately 8.70%.
- Cosmetic treatment segment leads the market, driven by countries like South Korea and Thailand.
- Private service providers dominate, offering advanced medical technologies and personalized care.
Market Size & Forecast
2024 Market Size: USD 58.83 Billion
2025 Market Size: USD 63.95 Billion
2034 Market Size: USD 135.50 Billion
CAGR (2025-2034): 8.70%.
Major Players
Apollo Hospital Enterprise Limited; Bumrungrad International Hospital; Fortis Healthcare Limited; KPJ Healthcare Berhad; Aditya Birla Memorial Hospital; Asian Heart Institute; Raffles Medical Group; Sunway Medical Centre; Yanhee Hospital; Mount Elizabeth Hospital.
Asia Medical Tourism Market Trends
High-quality healthcare services are driving the market growth
Asia is home to renowned healthcare professionals who possess extensive medical expertise and are highly skilled in their respective fields. Many Asian countries have developed strong medical education systems, producing doctors, surgeons, and specialists who are internationally recognized for their knowledge and expertise. Patients seeking specialized medical treatments are attracted to Asia for access to these highly qualified professionals. Asia has made substantial investments in healthcare infrastructure, resulting in state-of-the-art medical facilities equipped with advanced technologies. These facilities are on par with or even surpass those found in developed countries. The availability of cutting-edge medical equipment and technologies ensures that patients receive the most advanced and effective treatments, contributing to better medical outcomes. Many hospitals and healthcare institutions in Asia have obtained international accreditations and certifications. These accreditations, such as those from Joint Commission International (JCI), signify adherence to globally recognized standards of quality and safety. International accreditation helps build trust and confidence among medical tourists, assuring them of the high-quality care they will receive in Asian healthcare facilities.
Furthermore, Asia offers a wide range of medical procedures and treatments, including elective surgeries, cosmetic procedures, fertility treatments, cardiac surgeries, and more. These procedures are often readily available and have shorter waiting times compared to some countries with overloaded healthcare systems. Many hospitals and healthcare facilities in Asia have obtained international accreditation and certification from organizations such as Joint Commission International (JCI), ensuring compliance with globally recognized healthcare standards. This accreditation helps build trust and confidence among medical tourists, encouraging them to choose Asian healthcare providers. Asia attracts medical tourists from neighboring countries and regions due to cultural and language affinity. Proximity, shared cultural values, and language similarities make it easier for patients from nearby countries to travel to Asia for medical treatments, facilitating a seamless experience.

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Asia Medical Tourism Market Segment Insights:
Medical Tourism Treatment Type Insights
The Asia Medical Tourism market segmentation, based on treatment type includes Dental Treatment, Cosmetic Treatment, Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment, and Other Treatments. The cosmetic treatment segment dominated the market. Cosmetic treatments, including procedures like plastic surgery, facelifts, liposuction, and breast augmentation, have been a significant driver of medical tourism in Asia. Countries like South Korea, Thailand, and India have gained a reputation for offering high-quality cosmetic treatments at competitive prices, attracting patients from around the world.
Medical Tourism Service Provider Insights
The Asia Medical Tourism market segmentation, based on service provider, includes Public and Private. The private category generated the most income. Private hospitals, clinics, and healthcare facilities often dominate the Asia Medical Tourism Market. These private providers offer a wide range of medical services and treatments, including specialized procedures. They invest in state-of-the-art infrastructure, advanced medical technologies, and highly skilled healthcare professionals to attract medical tourists. Private service providers are known for their personalized care, shorter waiting times, and a focus on delivering a premium patient experience.
Figure 1: Asia Medical Tourism Market, by Service Provider, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Medical Tourism Country Insights
Asia is significant cost savings compared to developed countries. Patients from countries with high healthcare costs, such as the United States and Western Europe, often travel to Asia for medical treatments and procedures because they can receive high-quality care at a fraction of the cost. China has become a significant player in the medical tourism industry, attracting a growing number of international patients. China has made substantial investments in healthcare infrastructure and advanced medical technologies. Major cities like Beijing, Shanghai, and Guangzhou are home to world-class hospitals and clinics equipped with state-of-the-art facilities and equipment. China is known for its expertise in areas such as traditional Chinese medicine, organ transplants, oncology, and cardiovascular treatments. Moreover, China is renowned for its traditional Chinese medicine practices, which have gained popularity among medical tourists seeking holistic and alternative treatments. TCM clinics offer services such as acupuncture, herbal medicine, and therapeutic massages. Many patients travel to China to experience the benefits of TCM and its integration with modern medicine. China offers cost-effective medical treatments compared to many Western countries, making it an attractive destination for medical tourists seeking affordable healthcare solutions. The lower cost of procedures, medications, and hospital stays in China can result in significant savings for international patients.
Figure 2: ASIA Medical Tourism MARKET SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Asia Medical Toursim Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the medical tourism market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, medical tourism industry must offer cost-effective items.
Major players in the medical tourism market are attempting to increase market demand by investing in research and development operations includes Apollo Hospital Enterprise Limited; Bumrungrad International Hospital; Fortis Healthcare Limited; KPJ Healthcare Berhad; Aditya Birla Memorial Hospital; Asian Heart Institute; Raffles Medical Group; Sunway Medical Centre; Yanhee Hospital; Mount Elizabeth Hospital.   Â
Key Companies in the medical tourism market include
- Apollo Hospital Enterprise Limited
- Bumrungrad International Hospital
- Fortis Healthcare Limited
- KPJ Healthcare Berhad
- Aditya Birla Memorial Hospital
- Asian Heart Institute
- Raffles Medical Group
- Sunway Medical Centre
- Yanhee Hospital
- Mount Elizabeth Hospital
Asia Medical Tourism Market Developments
-
Q2 2024: Malaysia's IHH Healthcare appoints new CEO to drive international expansion IHH Healthcare, one of Asia's largest private hospital groups, announced the appointment of a new CEO in April 2024, signaling a renewed focus on expanding its medical tourism business across Asia.
-
Q2 2024: Bumrungrad International Hospital opens new specialized cancer center in Bangkok Bumrungrad International Hospital, a leading medical tourism destination in Thailand, inaugurated a state-of-the-art cancer center in May 2024 to attract more international patients seeking advanced oncology treatments.
-
Q2 2024: Raffles Medical Group launches new international patient services hub Raffles Medical Group opened a dedicated international patient services hub in Singapore in June 2024, aiming to streamline care for medical tourists from across Asia and beyond.
-
Q3 2024: Apollo Hospitals partners with Japan’s JTB Corp to boost inbound medical tourism Apollo Hospitals announced a strategic partnership with Japan’s JTB Corp in July 2024 to facilitate medical travel from Japan to India, focusing on advanced treatments and wellness services.
-
Q3 2024: Singapore’s Parkway Pantai opens new cardiac center targeting foreign patients Parkway Pantai, a major healthcare provider in Asia, opened a new cardiac center in August 2024, specifically designed to serve the growing number of international medical tourists seeking heart treatments.
-
Q3 2024: Thailand’s BDMS acquires stake in Vietnam’s City International Hospital Bangkok Dusit Medical Services (BDMS), a leading Thai hospital group, acquired a significant stake in City International Hospital in Ho Chi Minh City in September 2024, expanding its medical tourism network in Southeast Asia.
-
Q4 2024: KPJ Healthcare launches new flagship hospital in Kuala Lumpur to attract medical tourists KPJ Healthcare, Malaysia’s largest private hospital chain, opened a new flagship hospital in Kuala Lumpur in October 2024, featuring international patient suites and multilingual staff to cater to foreign patients.
-
Q4 2024: India’s Fortis Healthcare secures $100 million investment to expand medical tourism services Fortis Healthcare announced in November 2024 that it raised $100 million in new funding to enhance its international patient services and upgrade facilities catering to medical tourists.
-
Q4 2024: Singapore’s Health Management International opens new specialist center in Johor for cross-border patients Health Management International (HMI) opened a new specialist center in Johor, Malaysia, in December 2024, targeting Singaporean and Indonesian medical tourists seeking affordable care.
-
Q1 2025: Japanese government grants regulatory approval for foreign patient telemedicine pilot In January 2025, Japan’s Ministry of Health approved a pilot program allowing accredited hospitals to provide telemedicine consultations to foreign patients, aiming to boost inbound medical tourism.
-
Q1 2025: Hong Kong’s Gleneagles Hospital launches international concierge service for medical tourists Gleneagles Hospital in Hong Kong introduced a new international concierge service in February 2025 to assist overseas patients with travel, accommodation, and medical arrangements.
-
Q2 2025: Max Healthcare partners with UAE’s NMC Health to facilitate patient referrals Max Healthcare, a leading Indian hospital chain, entered into a partnership with UAE-based NMC Health in April 2025 to streamline patient referrals and cross-border medical travel between the two countries.
Asia Medical Tourism Market Segmentation
Medical Tourism Treatment Type Outlook
- Dental Treatment
- Cosmetic Treatment
- Cardiovascular Treatment
- Orthopedic Treatment
- Neurological Treatment
- Cancer Treatment
- Fertility Treatment
- Other Treatments
Medical Tourism Service Provider Outlook
Medical Tourism Regional Outlook
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Vietnam
- Malaysia
- Singapore
- Rest of Asia-Pacific
Report Attribute/Metric |
Details |
Market Size 2024 |
 58.83 (USD Billion) |
Market Size 2025 |
 63.95 (USD Billion) |
Market Size 2034 |
 135.50 (USD Billion) |
Compound Annual Growth Rate (CAGR) |
  8.70 % (2025 - 2034) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year |
2024 |
Market Forecast Period |
2025 - 2034 |
Historical Data |
2020 - 2024 |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Treatment Type, Service Provider, and Region |
Region Covered |
Asia-Pacific |
Countries Covered |
China, Japan, India, Australia, South Korea, Indonesia, Thailand, Vietnam, Malaysia, Singapore, and Rest of Asia-Pacific |
Key Companies Profiled |
Apollo Hospital Enterprise Limited; Bumrungrad International Hospital; Fortis Healthcare Limited; KPJ Healthcare Berhad; Aditya Birla Memorial Hospital; Asian Heart Institute; Raffles Medical Group; Sunway Medical Centre; Yanhee Hospital; Mount Elizabeth Hospital |
Key Market Opportunities |
·      Countries such as Malaysia, South Korea, Taiwan, Vietnam, and the Philippines are witnessing growth in their medical tourism sectors. |
Key Market Dynamics |
·      Globalization and Cross-Border Healthcare ·      Patient Experience and Customer Satisfaction |
Frequently Asked Questions (FAQ):
The Asia Medical Tourism market size was valued at USD 45.8 Billion in 2022.
The market is projected to grow at a CAGR of 8.70% during the forecast period, 2025-2034.
The key players in the market are Apollo Hospital Enterprise Limited; Bumrungrad International Hospital; Fortis Healthcare Limited; KPJ Healthcare Berhad; Aditya Birla Memorial Hospital; Asian Heart Institute; Raffles Medical Group; Sunway Medical Centre; Yanhee Hospital; Mount Elizabeth Hospital.
The cosmetic treatment category dominated the market in 2022.
The private category had the largest share in the market.